Cargando…

Obesity Management in the Primary Prevention of Hepatocellular Carcinoma

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is an increasingly prevalent and deadly disease driven in part by the rising obesity epidemic. Obesity causes HCC by initiating and progressing fatty liver disease. As such, weight reduction with the intention to treat fatty liver disease appears ideal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zunica, Elizabeth R. M., Heintz, Elizabeth C., Axelrod, Christopher L., Kirwan, John P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406638/ https://www.ncbi.nlm.nih.gov/pubmed/36011044 http://dx.doi.org/10.3390/cancers14164051

Ejemplares similares

Phytochemical Targeting of Mitochondria for Breast Cancer Chemoprevention, Therapy, and Sensitization
por: Zunica, Elizabeth R. M., et al.
Publicado: (2022)

Mitochondrial uncoupling attenuates sarcopenic obesity by enhancing skeletal muscle mitophagy and quality control
por: Dantas, Wagner S., et al.
Publicado: (2022)

GDF15 Mediates the Effect of Skeletal Muscle Contraction on Glucose-Stimulated Insulin Secretion
por: Zhang, Hui, et al.
Publicado: (2023)

The Role of Nutrition in Mitigating the Effects of COVID-19 from Infection through PASC
por: Mey, Jacob T., et al.
Publicado: (2023)

Carbon Ion Radiotherapy in the Management of Hepatocellular Carcinoma
por: Abousaida, Belal, et al.
Publicado: (2021)

A familial natural short sleep mutation promotes healthy aging and extends lifespan in Drosophila
por: Pandey, Pritika, et al.
Publicado: (2023)

CRISPR/Cas9-engineered Drosophila knock-in models to study VCP diseases
por: Wall, Jordan M., et al.
Publicado: (2021)

Moringa Oleifera Seed Extract Concomitantly Supplemented with Chemotherapy Worsens Tumor Progression in Mice with Triple Negative Breast Cancer and Obesity
por: Zunica, Elizabeth R. M., et al.
Publicado: (2021)

Contemporary Strategies in the Management of Hepatocellular Carcinoma
por: Khorsandi, Shirin Elizabeth, et al.
Publicado: (2012)

Hepatocellular Carcinoma and Hepatitis: Advanced Diagnosis and Management with a Focus on the Prevention of Hepatitis B-Related Hepatocellular Carcinoma
por: Kim, Soo Ryang, et al.
Publicado: (2023)

Proton Therapy in the Management of Hepatocellular Carcinoma
por: Kobeissi, Jana M., et al.
Publicado: (2022)

Pathogenesis to management of hepatocellular carcinoma
por: Da, Ben L., et al.
Publicado: (2022)

Animal Models of Hepatocellular Carcinoma Prevention
por: Shankaraiah, Ram C., et al.
Publicado: (2019)

BAM15‐mediated mitochondrial uncoupling protects against obesity and improves glycemic control
por: Axelrod, Christopher L, et al.
Publicado: (2020)

Intraarterial Therapies for the Management of Hepatocellular Carcinoma
por: Garg, Tushar, et al.
Publicado: (2022)

Hepatitis B Virus and Primary Hepatocellular Carcinoma
por: Sutton, R. N. P.
Publicado: (1982)

Dynamin-related protein 1 regulates substrate oxidation in skeletal muscle by stabilizing cellular and mitochondrial calcium dynamics
por: King, William T., et al.
Publicado: (2021)

HEPATOCELLULAR CARCINOMA: DIAGNOSIS AND OPERATIVE MANAGEMENT
por: CHEDID, Marcio F., et al.
Publicado: (2017)

Hepatocellular carcinoma: natural history, current management, and emerging tools
por: Tinkle, Christopher L, et al.
Publicado: (2012)

Immune checkpoint inhibition: prospects for prevention and therapy of hepatocellular carcinoma
por: Elsegood, Caryn L, et al.
Publicado: (2017)

Controversies in the management of hepatocellular carcinoma
por: Forner, Alejandro, et al.
Publicado: (2019)

Differential progression of unhealthy diet-induced hepatocellular carcinoma in obese and non-obese mice
por: Hymel, Emma, et al.
Publicado: (2022)

Obesity in primary care: prevention, management and the paradox
por: Haslam, David
Publicado: (2014)

Molecular Mechanisms Regulating Obesity-Associated Hepatocellular Carcinoma
por: Rajesh, Yetirajam, et al.
Publicado: (2020)

Antioxidant Role of Kaempferol in Prevention of Hepatocellular Carcinoma
por: Sharma, Nidhi, et al.
Publicado: (2021)

Management of Hepatocellular Carcinoma: Bangladesh Perspective
por: Noor-E-Alam, Sheikh M
Publicado: (2018)

Obesity, the most common comorbidity in SARS-CoV-2: is leptin the link?
por: Rebello, Candida J., et al.
Publicado: (2020)

Viral Hepatitis and Hepatocellular Carcinoma Prevention Strategy in Japan
por: Oda, Toshitsugu
Publicado: (1999)

Liver regeneration microenvironment of hepatocellular carcinoma for prevention and therapy
por: Li, Hanmin, et al.
Publicado: (2016)

Peretinoin, an Acyclic Retinoid, for the Secondary Prevention of Hepatocellular Carcinoma
por: Woo, Hyun Young, et al.
Publicado: (2021)

Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular Carcinoma
por: Alqahtani, Saleh A., et al.
Publicado: (2021)

Lifestyle and Hepatocellular Carcinoma What Is the Evidence and Prevention Recommendations
por: Zelber-Sagi, Shira, et al.
Publicado: (2021)

Hepatocellular Carcinoma Prevention in the Era of Hepatitis C Elimination
por: Lazarus, Jeffrey V., et al.
Publicado: (2023)

Updates on the Diagnosis and Management of Hepatocellular Carcinoma
por: Raees, Aimun, et al.
Publicado: (2021)

Update on new approaches in the management of hepatocellular carcinoma
por: Cabibbo, Giuseppe, et al.
Publicado: (2010)

Evolving role of Sorafenib in the management of hepatocellular carcinoma
por: Ziogas, Ioannis A, et al.
Publicado: (2017)

Hepatocellular carcinoma: early-stage management challenges
por: Erstad, Derek J, et al.
Publicado: (2017)

The management of post-transplantation recurrence of hepatocellular carcinoma
por: Rajendran, Luckshi, et al.
Publicado: (2022)

Hepatocellular Carcinoma: Surveillance, Diagnosis, Evaluation and Management
por: Elderkin, Jessica, et al.
Publicado: (2023)

Current Trends in Surgical Management of Hepatocellular Carcinoma
por: Angeli-Pahim, Isabella, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kpmo2f3754cnvlgs4a0vagrf50